<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Obrien Petersson | Activity</title>
	<link>https://brycefoster.com/members/gandergeese6/activity/</link>
	<atom:link href="https://brycefoster.com/members/gandergeese6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Obrien Petersson.</description>
	<lastBuildDate>Mon, 22 Jun 2026 06:23:58 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">f3266003594edd24065827742bc127a7</guid>
				<title>Obrien Petersson posted an update: Navigating GLP-1 Medications in Germany: A Comprehensive [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1521508/</link>
				<pubDate>Sun, 05 Apr 2026 14:57:28 +0000</pubDate>

									<content:encoded><![CDATA[<p>Navigating GLP-1 Medications in Germany: A Comprehensive Guide to Availability, Regulation, and Access</p>
<p>The landscape of metabolic health and weight management has undergone a significant change with the intro of Glucagon-like peptide-1 (GLP-1) receptor agonists. In Germany, these medications&#8211; initially established for the treatment of Type 2&hellip;<span class="activity-read-more" id="activity-read-more-1521508"><a href="https://brycefoster.com/activity/p/1521508/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9a78716740c478bf936de8926f0c3d26</guid>
				<title>Obrien Petersson became a registered member</title>
				<link>https://brycefoster.com/activity/p/1521459/</link>
				<pubDate>Sun, 05 Apr 2026 14:46:16 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>